Lactarius Indigo
Lactarius Indigo
Lactarius Indigo
Aqueous and organic basidiocarp extracts of the edible mushroom Lactarius indigo were evaluated for
their antibacterial and cytotoxic effects. 10, 20 and 30 mg of organic extracts were tested against
diarrheagenic Escherichia coli strains (EIEC, EPEC, ETEC-LT and ETEC-ST), Pseudomonas aeruginosa,
Enterobacter cloacae, Staphylococcus aureus and Salmonella enterica. 10 mg of hexane extract
showed activity against ETEC-LT (18.8 mm zone of inhibition) and P. aeruginosa (10.5 mm). All levels of
the ethyl acetate extract inhibited all the strains, with stronger activity against EIEC (19.0 mm) and P.
aeruginosa (21.0 mm) at 30 mg. Methanol extract inhibited all bacterial growth, but E. cloacae. 100 g/ml
of aqueous extract showed antiproliferative activity against MCF7 cells, but not on HeLa, A549 and
normal bovine mammary epithelium cells. Methanol and ethyl acetate extracts inhibited proliferation of
HeLa cells (50 to 1000 ng/ml) but increased proliferation of A549 (100 ng/ml), as did methanol extract
(500 ng/ml). Methanol extract did not inhibit normal rabbit serum fibroblast cells, while hexane and ethyl
acetate extracts showed an inhibitory effect with 50 and 100 ng/ml, respectively, less than in
proliferation of HeLa cells. These results show that L. indigo basidiocarps contain substances with
antibacterial and cytotoxic activities.
Key words: Lactarius indigo extracts, antibacterial activity, cytotoxic activity.
INTRODUCTION
Fungi from the division Basidiomycota have been widely
studied as an alternative source of metabolites with
pharmacological properties, including anticancerigenous,
antitumor, immunomodulating, antibacterial and cytotoxic
activities (Wasser, 2002; Daba and Ezeronye, 2003; Fan
et al., 2006; Borchers et al., 2008). Antibiotic resistance
of human pathogenic bacteria has become a major
worldwide public health concern (Finch, 2002; Harbarth
and Samore, 2005), this is why the search for new
substances with antimicrobial activity is a priority
(Livermore, 2005). Antimicrobial activity has already been
documented in extracts from the mycelium (Suay et al.,
2000) and fruiting bodies (Zjawioney, 2004) of differ-
282
Test microorganisms
Strains of Escherichia coli EPEC, ETEC, and EIEC pathotypes
used for the antibacterial activity assays were purchased from the
Institute of Diagnostic and Epidemic Reference of Mxico (InDRE,
Table 1). The Childrens Hospital Eva Smano de Lpez Mateos of
Morelia, Michoacn, Mexico, donated the tested strains of Pseudomonas aeruginosa, Enterobacter cloacae, and Salmonella enterica
subsp. enterica. The tested strain of Staphylococcus aureus was
ATCC27543.
Cell lines
Several cell lines corresponding to human cancers were used for
the cytotoxicity assays: HeLa (cervicouterine cancer), MCF7 (breast
Cytotoxicity assays
For cytotoxicity assays four different concentrations were used of
the organic extracts and the same volume of the corresponding
solvent as a control. All tested cell lines were cultivated to
confluence as described above and were detached from the culture
plate using PBS saline solution at pH 7.4 supplemented with
antibiotics and 0.25% trypsin-EDTA (w/v, Sigma, USA) and agitated
Zarzosa et al.
RESULTS
Antibacterial activity
The controls showed that hexane alone did not cause
any inhibition to the tested strains whereas the ethyl
acetate and methanol caused a minimal inhibition that
was subtracted as described in Materials and Methods.
The hexane extract caused inhibition of P. aeruginosa
and ETEC-LT (Table 2). For the ETEC-LT strain, 10 and
20 mg of hexane extract did not show significant
differences in the inhibition zone diameter but 30 mg
caused a significantly larger inhibition zone diameter than
that for lower amounts. For P. aeruginosa, the maximum
inhibition was observed at 20 mg of hexane extract, since
no significant differences could be observed with 20 and
30 mg of the extract (Table 2). The compounds present in
the hexane extract had a greater effect on the ETEC-LT
strain than on P. aeruginosa. The inhibition caused by the
hexane extract is comparable with that caused by the
standard antibiotics AM and CB (Table 1).
The ethyl acetate extract inhibited all tested strains
(Table 2). In all strains, except for ETEC-LT and S.
enterica, an apparent dose-response effect could be
observed, since the inhibition increased in relation to the
applied level of ethyl acetate extract. No significant
differences could be observed in E. cloacae and S.
aureus when applying the two lower amounts of the
extract. At 10 mg of ethyl acetate extract, no differences
could be observed in the inhibition of any of the tested
microorganisms. However, at 20 and 30 mg of ethyl
acetate extract, significant differences were observed in
the inhibition of P. aeruginosa, EIEC, ETC-ST, and EPEC
(Table 2). At the highest level, all strains showed different
susceptibilities to the ethyl acetate extract, except for E.
cloacae and S. aureus. The inhibition of the different E.
coli pathotypes caused by 30 mg of the ethyl acetate
extract was comparable to that caused by AM and CB,
except for strain ETEC-LT (Table 1).
283
284
Table 1. Reference strains and clinical isolates used in the present study.
Strain
E. coli
S.
P.
E.
S.
a
Pathotype/comment
Enterotoxigenic with heat-labile toxin (ETEC-LT)
Enterotoxaemia with heat-stable toxin (ETEC-ST)
Enteroinvasive (EIEC)
Enteropathogenic (EPEC)
isolated from bovine mastitis
clinical isolate
clinical isolate
clinical isolate
aureus
aeruginosa
cloacae
enterica subsp. enterica
AM a
18.0
16.0
20.0
15.0
nt
nt
nt
nt
Code
H10407
25611
E11
O111
ATCC27543
VGPM01
VGEM17
VGSM33
CBa
17.0
18.0
12.0
12.0
nt
nt
nt
nt
Inhibition zone diameter (mm) caused by 10 g of ampicillin (AM) and 100 g of carbenicillin (CB), nt, not tested.
Bacteria
10
E. coli
EIEC
EPEC
ETEC-LT
ETEC-ST
P. aeruginosa
E. cloacae
S. aureus
S. enterica
18.8 (0.73)1,a
10.5 (0.51)2,a
-
18.6 (0.30)1,a
11.2 (0.75)2,ab
-
30
10
21.0 (0.80)1,b
12.1 (0.52)2,b
-
9.6 (0.58)1,a
9.3 (0.52)1,a
10.5 (0.73)1,a
10.0 (0.19)1,a
9.6 (0.33)1,a
9.7 (0.36)1,a
10.1 (0.29)1,a
9.7 (0.75)1,a
Ethyl acetate
20
14.0 (0.73)1,b
12.0 (0.50)2,3,b
11.3 (0.53)3,5,a
13.0 (0.75)1,2,b
17.2 (0.25)4,b
10.1 (0.75)5,a
11.3 (0.65)3,5,a
11.0 (0.58)3,5,a
30
10
Methanol
20
30
19.0 (0.58)1,c
15.3 (0.15)2,c
12.0 (0.78)3,a
17.1 (0.53)4,c
21.0 (0.65)5,c
13.5 (0.17)6,b
13.0 (0.73)3, 6,b
11.0 (0.59)7,a
11.3 (0.53)1,a
11.0 (0.78)1,a
11.6 (0.15)1,a
10.7 (0.58)1,a
13.3 (0.53)2,a
9.6 (0.18)3, a
13.2 (0.38)2,a
16.0 (0.31)1, b
12.3 (0.22)2,b
17.0 (0.73)1,b
15.0 (0.31)3,b
15.1 (0.53)3,b
13.6 (0.15)4,a
14.0 (0.78)3,4,b
13.7 (0.17)4,a
20.6 (0.31)1,c
14.3 (0.58)2,5,c
17.6 (0.15)3,b
16.0 (0.73)3,4,b
15.3 (0.15)4,b
19.0 (0.73)1,b
16.3 (0.29)3,c
13.6 (0.15)5,a
*The mean radius of the inhibition zone of three independent experiments is shown in mm (SD). Values in the same row with the same superscript letter have non-significant differences
between them. Values in the same column with the same superscript number have non-significant differences between them. For both rows and columns, the significance test was
evaluated at p < 0.05. This significance analysis was made only for results within the same kind of extract for all levels tested.
-, no inhibition zone.
Zarzosa et al.
1.00
BME
HeLa
A549
285
MCF7
0.90
0.80
Optical density
0.70
0.60
0.50
0.40
0.30
0.20
0.10
0.00
0. 00
1.00
5.00
10.00
50.00
100.00
Extract concentration (
g/ml)
Figure 1. Effect of aqueous extract of L. indigo basidiocarp on proliferation of the four cell types evaluated. Bars represent the
mean of sextuplicates with its relative standard error. Asterisks indicate extract doses having significant differences relative to
the control (deionized water).
286
HX
0.20
EA
MeOH
0.16
Optical density
**
0.12
0.08
0.04
0.00
0
50
100
500
1000
0.30
0.25
Optical density
0.20
0.15
*
*
0.10
**
*
0.05
*
*
0.00
0
50
100
500
1000
0.25
*
Optical density
0.20
*
0.15
0.10
0.05
0.00
0
50
100
500
1000
Zarzosa et al.
287
288
cytotoxic,
antiviral,
antiproliferative and immunotropic activities in vitro. Planta Med., 72
(7): 615-620.
Len-Guzmn MF, Silva I, Lpez MG (1997). Proximate chemical
composition, free amino acid contents, and free fatty acid contents of
some wild edible mushrooms from Quertaro, Mxico. J. Agric. Food
Chem., 45(11): 4329-4332.
Livermore D (2005). Minimising antibiotic resistance. Lancet Infect. Dis.,
5(7): 450-459.
Lord CJ, Ashworth A (2010). Biology-driven cancer drug development:
back to the future. BMC Biol., 8:38. Doi:10.1186/1741-7007-8-38.
Martnez-Carrera D, Nava D, Sobal M, Mayett Y (2005). Marketing
channels for wild and cultivated edible mushrooms in developing
countries: the case of Mexico. Micol. Apl. Int., 17(2): 9-20.
Mlinaric A, Kac J, Fatur T, Filipic M (2004). Anti-genotoxic activity of the
mushroom Lactarius vellerus extract in bacteria and in mammalian
cells in vitro. Pharmazie., 59(3): 217-221.
Montoya L, Bandala V (1996). Additional new records on Lactarius
from Mexico. Mycotaxon, 57(1): 425-450.
Montoya-Esquivel A, Estrada-Torres A, Kong A, Jurez-Snchez L
(2001). Commercialization of wild mushrooms during market days of
Tlaxcala, Mexico. Micol. Apl. Int., 13(1): 31-40.
Montoya A, Hernndez-Totomoch O, Estrada-Torres A, Kong A,
Caballero J (2003). Traditional knowledge about mushrooms in a
Nahua community in the state of Tlaxcala, Mxico. Mycologia, 95(5):
793-806.
Mueller G, Halling R (1995). Evidence for high Biodiversity of Agaricales
(Fungi) in Neotropical Montane Quercus Forest. In: Churchill SP (ed)
Biodiversity and conservation of Neotropical montane forests, The
New York Botanical Garden, New York, pp. 303-312.
National Committee for Clinical Laboratory Standards (NCCLS) (1993).
Performance standard for antimicrobial disc susceptibility test.
Approved Standard NCCLS Publications M2-A5 (ISBN 1-56238-3779). NCCLS, 940, West Valley, Pennsylvania 19087, USA.
Prez-Silva E, Esqueda M, Herrera T, Coronado M (2006). New records
of Agaricales from Sonora, Mxico. Rev. Mex. Biodiv., 77(1): 23-33.
Shang D, Zhang J, Wen L, Li Y, Cui Q (2009). Preparation,
characterization, and antiproliferative activities of the Se-containing
polysaccharide SeGLP-2B-1 from Se-enriched Ganoderma lucidum.
J. Agric. Food Chem., 57(17): 7737-7742.
Suay I, Arenal F, Asensio FJ, Basilio A, Cabello MA, Dez MT, Garca
JB, del Val A G, Gorrochategui J, Hernndez P, Pelez F, Vicente
MF (2000). Screening of basidiomycetes for antimicrobial activities.
Antonie Van Leeuwenhoek, 78(2): 129-139.
Takaku T, Kimura Y, Okuda H (2001). Isolation o fan antitumor
compound from Agaricus blazei Murril and its mechanisms of action.
J Nutr., 131(5): 1409-1413.
Talorete TPN, Isoda H, Maekawa T (2002). Agaricus blazei (Class
Basidiomycotina) aqueous extract enhances the expression of c-Jun
protein in MCF7 cells. J. Agric. Food Chem., 50 (18): 5162-5166.
Tong H, Xia F, Feng K, Sun G, Gao X, Sun L, Jiang R, Tian D, Sun X
(2009). Structural characterization and in vitro antitumor activity of a
novel polysaccharide isolated from the fruiting bodies of Pleurotus
ostreatus. Bioresour Technol., 100(4): 1682-1686.
A, Demirbilek M, Turkoglu M, Celik A, Mazmanci MA, Erkurt EA,
nyayar S, Cekic , Atacag H (2006). Evaluation of cytotoxic and
mutagenic effects of Coriolus versicolor and Funalia trogii extracts on
mammalian cells. Drug Chem. Toxicol., 29(1):69-83.
Vidari G, Vita-Finzi P, Zanocchi AM, Noy GP (1995). Bioactive
tetraprenylphenol from Lactarius lignyotus. J. Nat. Prod., 58(6): 893896.
Wasser SP (2002). Medicinal mushrooms as a source of antitumor and
immunomodulating polysaccharides. Appl. Microbiol. Biotechnol.,
60(3):258-274.
World Health Organization (WHO) (2002). National cancer control
nd
programmes: policies and managerial guidelines. 2 ed. Geneva.
Wu Q, Mueller GM (1997). Biogeographic relationships between the
macrofungi of temperate eastern Asia and eastern North America.
Can. J. Bot., 75(12): 2108-2115.
Yan D, Bao HY, Bau T, Li Y, Kim YH (2009). Antitumor components from
Naematoloma fasciculare. J. Microbiol. Biotechnol., 19(10): 1135-1138.
Zjawiony KJ
(2004). Biologically active compounds
from
Aphyllophorales (Polypore) Fungi. J. Nat. Prod., 67(2): 300-310.